David Nutt and Sophie Macken are the guest editors with experts contributing a series of articles that critically assess and challenge the coalition's drug strategy.
Eric Carlin argues that ultimately the strategy will disappoint and Neil McKeganey considers the rationale behind it.
The topical and comment sections cover a range of contemporary issues including the usefulness of criminal profiling, the exercise of power and authority in prison, and debating the use of victim personal statements in court.
In this edition
Tammy McGloughlin and Will McMahon introduce this issue of cjm
By Tammy McGloughlin and Will McMahon
On 20 January this year, the Centre for Crime and Justice Studies held its Annual Event
By Vincenzo Ruggiero, Vivien Stern, Rod Morgan and David Nutt
Craig Jackson, David Wilson and Baljit Kaur Rana review some of the evidence on the profiling process
By Craig Jackson, David Wilson and Baljit Kaur Rana
David Scott highlights the exercise of power and authority in prison
By David Scott
Peter Hungerford-Welch argues that speed must not be achieved at the expense of the right of the accused to a fair trial
By Peter Hungerford-Welch
David Nutt and Sophie Macken introduce the themed section of cjm
By David Nutt and Sophie Macken
Eric Carlin argues that the failure to refocus from criminal justice to public health means the Strategy will ultimately disappoint
By Eric Carlin
Patrick Hargreaves considers different approaches for getting effective messages across to young people
By Patrick Hargreaves
Alex Stevens examines the tensions between rhetoric and action in the government’s new approach to drug treatment
By Alex Stevens
Emma Wincup explores both the New Labour government’s and the Coalition’s proposals to tackle problem drug users through welfare reform
By Emma Wincup
‘New’ Strategy, usual suspects: a critique of reducing demand, restricting supply, building recovery
Stuart Taylor argues that the focus on the ‘usual suspects’ will not do
By Stuart Taylor
Fiona Measham considers the policy challenges for regulating ‘novel’ drugs
By Fiona Measham
Jonathan Birdwell and Nicola Singleton argue that it is time for a fundamental review of the current system of drug control
By Jonathan Birdwell and Nicola Singleton
By Helen Mills, Rebecca Roberts, George Mair, Jamie Bennett and Mick Ryan
Neil McKeganey considers the rationale behind the strategy
By Neil McKeganey
Rachel Herzing and Isaac Ontiveros describe the aims prompting an abolitionist framework
By Rachel Herzing and Isaac Ontiveros
